AVE 0.00% 0.2¢ avecho biotechnology limited

Three new Directors appointed, page-18

  1. 8,604 Posts.
    lightbulb Created with Sketch. 83
    ..so who's selling..and why?

    solid financials, ph 2 oxyc underway, oxym ph 2 to begin Q3, both with multi bill markets, global IAH territories imminent with an increasing income stream..everything points to a buy


    ..fair to say some bullshit involved here?
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.